Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
The American Journal of Gastroenterology|December 1, 1989
Acute necrotizing gastritis in a patient with peptic ulcer diseaseL B Stein, R E Greenberg, C F Ilardi, et al.British Journal of Urology|August 1, 1997
The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancerM Alagiri, M D Colton, E J Seidmon, et al.Growth, Development, and Aging : GDA|January 1, 1991
Growth retardation during the suckling period in expanded litters of rats: observations of growth patterns and protein turnoverJ D Johnson, W J Wogenrich, K C Hsi, et al.Cancer Research|December 15, 1995
Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathologyC A Thrash-Bingham, H Salazar, J J Freed, et al.Urology|August 1, 1992
Hoarseness; a unique clinical presentation for renal cell carcinomaR E Greenberg, J Cooper, R L Krigel, et al.Cancer Genetics and Cytogenetics|February 15, 2001
Loss of the short arm of the Y chromosome in human prostate carcinomaJ J Jordan, A L Hanlon, T I Al-Saleem, et al.Diabetes|May 1, 1990
Fetal hyperinsulinemia and protein turnover in fetal rat tissuesJ D Johnson, T Dunham, F J Wogenrich, et al.Biochimica Et Biophysica Acta|October 8, 1987
Glutathione S-transferases in human prostateK D Tew, M L Clapper, R E Greenberg, et al.Urology|August 5, 2000
Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancerA L Patterson, R E Greenberg, L Weems, et al.Brachytherapy|December 3, 2014
Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessmentT Shaikh, N G Zaorsky, K Ruth, et al.Pageof 4